Interim Condensed Consolidated Statements Of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 27, 2025	Jun. 28, 2024	Jun. 27, 2025	Jun. 28, 2024
Revenue:
Revenue	$ 315,546	$ 288,818	$ 1,042,106	$ 968,915
Total revenue	315,546	288,818	1,042,106	968,915
Cost of revenue:
Total cost of revenue	44,002	35,663	120,613	106,500
Gross profit	271,544	253,155	921,493	862,415
Operating expenses:
Research and development	65,982	65,501	194,327	195,027
Sales and marketing	86,163	77,518	270,191	246,559
General and administrative	72,307	69,275	212,814	201,183
Restructuring charges	(547)	4,078	8,879	7,674
Total operating expenses	223,905	216,372	686,211	650,443
Operating income	47,639	36,783	235,282	211,972
Other income/(expense):
Interest income/(expense), net	4,111	9,439	10,316	27,223
Other income, net	3,766	3,942	16,219	13,550
Total other income	7,877	13,381	26,535	40,773
Income before income taxes	55,516	50,164	261,817	252,745
Provision for income taxes	(8,974)	(10,509)	(54,979)	(47,295)
Net income including noncontrolling interest	46,542	39,655	206,838	205,450
Less: net income attributable to noncontrolling interest	(471)	(1,211)	(1,152)	(2,195)
Net income attributable to Dolby Laboratories, Inc.	$ 46,071	$ 38,444	$ 205,686	$ 203,255
Net income per share:
Basic (in usd per share)	$ 0.48	$ 0.40	$ 2.14	$ 2.13
Diluted (in usd per share)	$ 0.48	$ 0.40	$ 2.11	$ 2.09
Weighted-average shares outstanding:
Basic (in shares)	95,897	95,686	95,947	95,593
Diluted (in shares)	96,900	96,959	97,537	97,412
Cash dividend declared per common share (in dollars per share)	$ 0.33	$ 0.30	$ 0.99	$ 0.90
Cash dividend paid per common share (in dollars per share)	$ 0.33	$ 0.30	$ 0.99	$ 0.90
Licensing
Revenue:
Revenue	$ 289,905	$ 267,082	$ 966,390	$ 899,089
Cost of revenue:
Cost of revenue	21,713	17,386	62,508	48,440
Products and services
Revenue:
Revenue	25,641	21,736	75,716	69,826
Cost of revenue:
Cost of revenue	$ 22,289	$ 18,277	$ 58,105	$ 58,060